Skip to main content

Value-Based Care in Cardiometabolic Health August 2012, Vol 1, No 2

The Ancient Anti-Inflammatory Drug Salsalate Lowers Blood Glucose Levels

Head-to-Head Comparison: Early Insulin Glargine Can Help Achieve Glycemic Target in Type 2 Diabetes

The Diabetes Epidemic Is Like a Tsunami Hitting in Waves

Lixisenatide Continues to Show Good Results in GetGoal Program Studies

Novel Basal Insulin LY2605541 Lowers Blood Glucose, Enhances Weight Loss

New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine

Incretin Impairment: The Role of GLP-1 and DPP-4 in Type 2 Diabetes Management

Medical Costs Increase as Chronic Kidney Disease Worsens

Value-Based Benefit Design: Reducing Copayment for High-Value Services Maximizes Return on Investment

Cardiometabolic Health

Diabetes Rates Surging Among American Youth

Page 2 of 4
Results 11 - 20 of 34